Availability of medical countermeasures for bioterrorism events: US legal and regulatory options.
Maher
C
C
Office of Counterterrorism and Emerging Threats, US Food and Drug Administration, US Department of Health and Human Services, Rockville, Maryland, USA. carmen.maher@fda.hhs.gov
Lushniak
B D
BD
D023482:Bioterrorism / Q000331:legislation & jurisprudence*; D004189:Disaster Planning / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D017277:Drug Approval; D004630:Emergencies; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D006801:Humans; D016365:Liability, Legal; D014481:United States; D014486:United States Food and Drug Administration